ZA896202B - Production of bluetongue virus non-structural proteins using a baculovirus expression vector - Google Patents
Production of bluetongue virus non-structural proteins using a baculovirus expression vectorInfo
- Publication number
- ZA896202B ZA896202B ZA896202A ZA896202A ZA896202B ZA 896202 B ZA896202 B ZA 896202B ZA 896202 A ZA896202 A ZA 896202A ZA 896202 A ZA896202 A ZA 896202A ZA 896202 B ZA896202 B ZA 896202B
- Authority
- ZA
- South Africa
- Prior art keywords
- production
- expression vector
- structural proteins
- baculovirus expression
- bluetongue virus
- Prior art date
Links
- 241000120506 Bluetongue virus Species 0.000 title 1
- 101710172711 Structural protein Proteins 0.000 title 1
- 239000013604 expression vector Substances 0.000 title 1
- 241000701447 unidentified baculovirus Species 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14141—Use of virus, viral particle or viral elements as a vector
- C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12311—Rotavirus, e.g. rotavirus A
- C12N2720/12322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB888819453A GB8819453D0 (en) | 1988-08-16 | 1988-08-16 | Production of bluetongue virus non-structural proteins using baculovirus expression vector |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA896202B true ZA896202B (en) | 1990-08-29 |
Family
ID=10642209
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA896202A ZA896202B (en) | 1988-08-16 | 1989-08-15 | Production of bluetongue virus non-structural proteins using a baculovirus expression vector |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0431038A1 (xx) |
| AU (1) | AU4198889A (xx) |
| GB (1) | GB8819453D0 (xx) |
| WO (1) | WO1990002186A1 (xx) |
| ZA (1) | ZA896202B (xx) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1324770A2 (en) * | 2000-09-27 | 2003-07-09 | The UAB Research Foundation | Non-replicative particulate vaccine delivery system and methods of making and using same |
| NZ548256A (en) | 2004-02-02 | 2010-02-26 | Ambrx Inc | Modified human four helical bundle polypeptides and their uses |
| KR20070034512A (ko) | 2004-06-18 | 2007-03-28 | 암브룩스, 인코포레이티드 | 신규 항원-결합 폴리펩티드 및 이의 용도 |
| CN103690936A (zh) | 2004-12-22 | 2014-04-02 | Ambrx公司 | 经修饰的人类生长激素 |
| WO2006073846A2 (en) | 2004-12-22 | 2006-07-13 | Ambrx, Inc. | Methods for expression and purification of recombinant human growth hormone |
| CA2927595C (en) | 2004-12-22 | 2023-01-31 | Ambrx, Inc. | Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
| BRPI0519170A8 (pt) | 2004-12-22 | 2018-05-08 | Ambrx Inc | formulações de hormônio de crescimento humano que compreendem um aminoácido não naturalmente codificado |
| CN102719366B (zh) | 2004-12-22 | 2014-07-16 | Ambrx公司 | 氨酰基-tRNA合成酶的组合物及其用途 |
| AU2006255122B2 (en) | 2005-06-03 | 2010-10-21 | Ambrx, Inc. | Improved human interferon molecules and their uses |
| AU2006315347A1 (en) | 2005-11-16 | 2007-05-24 | Ambrx, Inc. | Methods and compositions comprising non-natural amino acids |
| WO2008030613A2 (en) | 2006-09-08 | 2008-03-13 | Ambrx, Inc. | Hybrid suppressor trna for vertebrate cells |
| CA2663083A1 (en) | 2006-09-08 | 2008-03-13 | Ambrx, Inc. | Modified human plasma polypeptide or fc scaffolds and their uses |
| NZ574960A (en) | 2006-09-08 | 2012-02-24 | Ambrx Inc | Suppressor trna transcription in vertebrate cells |
| WO2008121563A2 (en) | 2007-03-30 | 2008-10-09 | Ambrx, Inc. | Modified fgf-21 polypeptides and their uses |
| NZ580686A (en) | 2007-05-02 | 2012-11-30 | Ambrx Inc | Modified interferon beta polypeptides and their uses |
| NZ603812A (en) | 2007-11-20 | 2014-06-27 | Ambrx Inc | Modified insulin polypeptides and their uses |
| CN103694337B (zh) | 2008-02-08 | 2016-03-02 | Ambrx公司 | 经修饰瘦素多肽和其用途 |
| EP3225248B1 (en) | 2008-07-23 | 2023-06-07 | Ambrx, Inc. | Modified bovine g-csf polypeptides and their uses |
| CA2738033C (en) | 2008-09-26 | 2019-11-26 | Ambrx, Inc. | Non-natural amino acid replication-dependent microorganisms and vaccines |
| CA2737026C (en) | 2008-09-26 | 2019-12-24 | Ambrx, Inc. | Modified animal erythropoietin polypeptides and their uses |
| MX349301B (es) | 2009-12-21 | 2017-07-21 | Ambrx Inc | Polipéptidos de somatotropina bovina modificados y sus usos. |
| CN104017063A (zh) | 2009-12-21 | 2014-09-03 | Ambrx公司 | 经过修饰的猪促生长素多肽和其用途 |
| DK2605789T3 (da) | 2010-08-17 | 2019-09-16 | Ambrx Inc | Modificerede relaxinpolypeptider og anvendelser deraf |
| US9567386B2 (en) | 2010-08-17 | 2017-02-14 | Ambrx, Inc. | Therapeutic uses of modified relaxin polypeptides |
| TWI480288B (zh) | 2010-09-23 | 2015-04-11 | Lilly Co Eli | 牛顆粒細胞群落刺激因子及其變體之調配物 |
| MX2017004947A (es) | 2014-10-24 | 2017-06-29 | Bristol Myers Squibb Co | Polipeptidos del factor de crecimiento de fibroblastos 2 (fgf-21) modificados y usos de los mismos. |
| KR102670432B1 (ko) | 2017-02-08 | 2024-05-28 | 브리스톨-마이어스 스큅 컴퍼니 | 약동학적 인핸서를 포함하는 변형된 렐락신 폴리펩티드 및 그의 용도 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU591459B2 (en) * | 1984-08-31 | 1989-12-07 | Research Corporation | cDNA probe for the detection of bluetongue virus |
| AP114A (en) * | 1987-02-19 | 1991-02-01 | Oxford Virology Ltd | Production of bluetongue virus antigens using a baculovirus expression vector. |
-
1988
- 1988-08-16 GB GB888819453A patent/GB8819453D0/en active Pending
-
1989
- 1989-08-15 ZA ZA896202A patent/ZA896202B/xx unknown
- 1989-08-15 WO PCT/GB1989/000939 patent/WO1990002186A1/en not_active Application Discontinuation
- 1989-08-15 EP EP89909839A patent/EP0431038A1/en not_active Withdrawn
- 1989-08-15 AU AU41988/89A patent/AU4198889A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU4198889A (en) | 1990-03-23 |
| EP0431038A1 (en) | 1991-06-12 |
| GB8819453D0 (en) | 1988-09-21 |
| WO1990002186A1 (en) | 1990-03-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA896202B (en) | Production of bluetongue virus non-structural proteins using a baculovirus expression vector | |
| GB8910381D0 (en) | A recombinant baculovirus,envelope protein of japanese encephalitis virus using said virus and process for producing the protein | |
| PT91631A (pt) | A process for the preparation of cyclic graf-analogs ii | |
| AU3756789A (en) | Antagonists of viral transactivating proteins | |
| IL89363A0 (en) | Expression of hiv binding proteins | |
| GB2225322B (en) | A process for the preparation of (s)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide | |
| AP8800083A0 (en) | Production of bluetongue virus antigens using a baculovirus expression vector | |
| GB8821507D0 (en) | Improvements relating to peptides | |
| GB2221904B (en) | Production of alkanols | |
| GB8817160D0 (en) | Novel proteins | |
| GB2193462B (en) | Location of jointed textiles in a mould | |
| GB9003489D0 (en) | A ring resonator gyro | |
| GB8817161D0 (en) | Modified proteins | |
| GB8825390D0 (en) | Production of chloride-free fertilizers-11 | |
| ZA893579B (en) | Antigenic polypeptides of taenia ovis | |
| ZA88849B (en) | Production of bluetongue virus antigens using a baculovirus expression vector | |
| IE883483L (en) | Expression of hiv proteins | |
| EP0323846A3 (en) | Process of preparing thiamphenicol | |
| AU100881S (en) | A set of foldable suspension tiles | |
| ZA893263B (en) | Production of polypeptides | |
| IE881482L (en) | Recombinant htlv-iii proteins | |
| ZA894489B (en) | Preparation of a demethyltetralin | |
| IE894106L (en) | Expression of the plasmodium circumsporozite protein in¹insects | |
| AU104945S (en) | A segment of a craypot upper | |
| IE881635L (en) | Human immunodeficiency virus gag-encoded proteins |